The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb.
Mol Genet Metab Rep
; 29: 100813, 2021 Dec.
Article
em En
| MEDLINE
| ID: mdl-34712576
1,5-anhydroglucitol-6-phosphate; 1,5AG, 1,5-anhydroglucitol; 1,5AG6P, 1,5-anhydroglucitol-6-phosphate; BM, bone marrow; CFU, colony forming units; Dapagliflozin; G-CSF, granulocyte colony stimulating factor; G6PC3, glucose-6-phosphatase C3; G6PT, glucose-6-phospate translocase; GSDIb, Glycogen Storage Disease type 1b; Glycogen storage disease type 1b; M-CSF, macrophage colony stimulating factor; Mouse model; NET, neutrophil extracellular trap; Neutrophils; PMA, phorbol myristate acetate; PRM, parallel reaction monitoring; Renal sodium-glucose co-transporter-2; SGLT2, sodium-glucose co-transporter-2; TM, tamoxifen; fMLP, N-formyl-L-methionyl-L-leucyl-phenylalanine
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Mol Genet Metab Rep
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Itália